Viewing Study NCT04601766


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-01-02 @ 8:45 AM
Study NCT ID: NCT04601766
Status: COMPLETED
Last Update Posted: 2021-06-30
First Post: 2020-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets
Sponsor: Asieris Pharmaceuticals (AUS) Pty Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module